Clinical Trials Logo
  1. Home
  2. Allergy to Cats
  3. NCT00620880
  4. Details
NCT00620880 Clinical Trial

IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Allergy to Cats Clinical Trial

Official title:
Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00620880
Other study ID # IVN-CAT-001A
Secondary ID
Status Completed
Phase N/A
First received February 11, 2008
Last updated November 19, 2008
Start date September 2005
Est. completion date September 2006

Study information
Verified date November 2008
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority Switzerland: Swissmedic
Study type Observational

Clinical Trial Summary

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date September 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion criteria: 1. Patient with Cat Dander Allergy evidenced by positive history 2. Age: 18 to 75 years

Exclusion criteria: 1. Use of oral corticosteroids, Chromoglycin, Ketotifen, or any immunosuppressive drugs within the last 2 months 2. Psychiatric disorder resulting in malcompliance 3. Neg. IgE to Cat dander

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Behavioral:
• Blood sample

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
University of Zurich ImVision AG

Country where clinical trial is conducted

Switzerland, 

See also
  Status Clinical Trial Phase
Completed NCT05455749 - Effect of holoBLG on Cat Allergic Patients N/A
Active, not recruiting NCT04619017 - Airway Immune Response to Allergens (Use Lay Language Here) Phase 1
Withdrawn NCT04401631 - Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation
Withdrawn NCT04442932 - abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies
Not yet recruiting NCT06069063 - Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander Challenge Phase 2
Completed NCT04678063 - Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma N/A